If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Allotment of Securities

20 Dec 2024 17:20

RNS Number : 0093R
UPL Limited
20 December 2024
 

UPL LIMITED

 

 

Sub: Outcome of Rights Issue Committee Meeting - Allotment of Securities

 

The Rights Issue Committee at its meeting held today i.e. Friday, 20th December, 2024, inter-alia, considered and approved the allotment of 9,37,92,629 partly paid-up Equity Shares at an issue price of ₹ 360 per Equity Share (including a premium of ₹ 358 per Equity Share) to eligible equity shareholders of which ₹ 90 per Equity Share (including a premium of ₹ 89.50 per Equity Share has been paid on application ("Allotment") and the balance amount shall be payable on one or more additional calls with terms and conditions such as the number of calls and the timing and quantum of each call as may be decided by the Board / Rights Issue Committee from time to time. Further, allotment of 33,326 Rights Equity Shares has been kept in abeyance pending regulatory/other clearances.

 

Links:

 

https://www.bseindia.com/xml-data/corpfiling/AttachLive/9dbd0845-8b18-46ed-bea1-c0e179f0860c.pdf

 

We request you to take note of the same.

 

Thanking you,

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CIRFLFLDFSLIFIS

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS